Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · July 18, 2022

Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel in Patients With Moderate to Severe Facial Acne Vulgaris

The British Journal of Dermatology


Additional Info

The British Journal of Dermatology
Efficacy and safety of N-acetyl-GED-0507-34-LEVO gel in patients with moderate-to severe facial acne vulgaris: a phase IIb randomized double-blind, vehicle-controlled trial
Br J Dermatol 2022 May 12;[EPub Ahead of Print], M Picardo, C Cardinali, M La Placa, A Lewartowska-Białek, V Lora, G Micali, R Montisci, L Morbelli, A Nova, A Parodi, A Reich, M Sebastian, K Turek-Urasińska, O Weirich, J Zdybski, CC Zouboulis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading